Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,623,432
  • Shares Outstanding, K 36,107
  • Annual Sales, $ 547,410 K
  • Annual Income, $ 48,460 K
  • 60-Month Beta 0.67
  • Price/Sales 15.61
  • Price/Cash Flow 189.16
  • Price/Book 13.72
Trade PEN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.14
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -152.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
183.55 +30.12%
on 10/02/20
241.80 -1.23%
on 10/27/20
+44.65 (+22.99%)
since 09/25/20
3-Month
183.55 +30.12%
on 10/02/20
241.81 -1.23%
on 08/13/20
+25.89 (+12.16%)
since 07/27/20
52-Week
121.80 +96.08%
on 03/23/20
241.81 -1.23%
on 08/13/20
+81.12 (+51.44%)
since 10/25/19

Most Recent Stories

More News
Medical Products Q3 Earnings on Oct 28: BSX, CERN & More

In Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions in many states and regions. However, international sales might have been dampened.

CERN : 72.74 (-0.18%)
BSX : 36.05 (-2.20%)
PEN : 238.83 (+0.90%)
LVGO : 142.89 (+4.55%)
Penumbra, Inc. Schedules Third Quarter 2020 Earnings Release and Conference Call for October 28, 2020

, /PRNewswire/ -- Penumbra, Inc. today announced that it will host a conference call to discuss financial results for the third quarter 2020 after market close on at 4:30 PM Eastern Time. Penumbra...

PEN : 238.83 (+0.90%)
Penumbra, Inc. to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 18th Annual Global Healthcare Conference on .

PEN : 238.83 (+0.90%)
Penumbra, Inc. to Present at the Wells Fargo 2020 Virtual Healthcare Conference

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo 2020 Virtual Healthcare Conference on .

PEN : 238.83 (+0.90%)
Penumbra (PEN) Reports Q2 Loss, Tops Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 37.50% and 6.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

PEN : 238.83 (+0.90%)
Penumbra: 2Q Earnings Snapshot

ALAMEDA, Calif. (AP) _ Penumbra Inc. (PEN) on Monday reported a second-quarter loss of $12 million, after reporting a profit in the same period a year earlier.

PEN : 238.83 (+0.90%)
Penumbra, Inc. Reports Second Quarter 2020 Financial Results

, /PRNewswire/ -- Penumbra, Inc.(NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended .

PEN : 238.83 (+0.90%)
Penumbra, Inc. to Present at the William Blair 40th Annual Growth Stock Conference

, /PRNewswire/ -- Penumbra, Inc. today announced that its management team is scheduled to present at the William Blair 40th Annual Growth Stock Conference on .

PEN : 238.83 (+0.90%)
Penumbra, Inc. Announces Pricing of Offering of Common Stock

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the pricing of an underwritten public offering of 753,012 shares of its common...

PEN : 238.83 (+0.90%)
Penumbra, Inc. Announces Launch of Offering of $100,000,000 of Shares of its Common Stock

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced that it has commenced an underwritten public offering of of shares of its common...

PEN : 238.83 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

2nd Resistance Point 245.32
1st Resistance Point 242.08
Last Price 238.83
1st Support Level 235.31
2nd Support Level 231.78

See More

52-Week High 241.81
Last Price 238.83
Fibonacci 61.8% 195.97
Fibonacci 50% 181.80
Fibonacci 38.2% 167.64
52-Week Low 121.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar